Verition Fund Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Hold |
|
|||||
|
2025
Q1 | $1.22M | Sell |
|
|||||
|
2024
Q4 | $4.02M | Sell |
|
|||||
|
2024
Q3 | $7.61M | Sell |
|
|||||
|
2024
Q2 | $11.6M | Buy |
|
|||||
|
2024
Q1 | $11.4M | Sell |
|
|||||
|
2023
Q4 | $12.8M | Sell |
|
|||||
|
2023
Q3 | $11.5M | Buy |
|
|||||
|
2023
Q2 | $8.5M | Buy |
|
|||||
|
2023
Q1 | $8.78M | Buy |
|
|||||
|
2022
Q4 | $6.1M | Buy |
|
|||||
|
2022
Q3 | $4.45M | Buy |
|
|||||
|
2022
Q2 | $792K | Sell |
|
|||||
|
2022
Q1 | $1.72M | Buy |
|
|||||
|
2021
Q4 | $2.54M | Buy |
|
|||||
|
2021
Q3 | $918K | Sell |
|
|||||
|
2021
Q2 | $2.4M | Buy |
|
|||||
|
2021
Q1 | $3.35M | Buy |
|
|||||
|
2020
Q4 | $2.64M | Buy |
|
|||||
|
2020
Q3 | $789K | Buy |
|